Caplin Point Laboratories Limited — Board Meeting, 07-02-2025: Outcome of Board Meeting

The Board of Directors of Caplin Point Laboratories has announced the outcome of their meeting, approving the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. For Q3 FY25, total revenue reached ₹524.32 crore, a 15.8% increase year-on-year, while profit before tax stood at ₹177.27 crore, reflecting a year-on-year growth of 21.9%. The company's operational performance highlights include robust gross profit and EBITDA margins of 60.4% and 36.9% respectively, indicating strong financial health and effective cost management strategies.